No doubt, but because he is Twiggy he can invest in Carina where I can't.
Having said that, here are the facts as I see them:
1AD owns the technology to produce a billion different antigen-receptors that Carina might need. This is a much better bet than having one shot on goal - that of making the solid tumor cells look like blood cancer cells that express a particular antigen (CD-19) and hoping your (CD-19) CAR-T works better than other (CD-19) CAR-T 's already out there.
And Carina own their technology.
So there is no licensing of technologies from US that no-one in the US wanted.
At a Market Cap of $25M you are getting a lot more bang for your buck here, I would think.
Also I don't have to read the stomach churning sycophantic adulation for entrepreneurs on the other company threads.
Just my opinions, possibly wrong.
1AD Price at posting:
10.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)